A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25–50 mg) in patients with major depressive disorder

Autor: Kennedy, Sidney H., Avedisova, Alla, Giménez-Montesinos, Natalia, Belaïdi, Carole, Christian de, Bodinat
Zdroj: In European Neuropsychopharmacology April 2014 24(4):553-563
Databáze: ScienceDirect